NGNE
Price
$19.94
Change
-$0.13 (-0.65%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
310.88M
Intraday BUY SELL Signals
ZNTL
Price
$1.36
Change
-$0.02 (-1.45%)
Updated
Dec 26 closing price
Capitalization
99.71M
67 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NGNE vs ZNTL

Header iconNGNE vs ZNTL Comparison
Open Charts NGNE vs ZNTLBanner chart's image
Neurogene
Price$19.94
Change-$0.13 (-0.65%)
Volume$1.82K
Capitalization310.88M
Zentalis Pharmaceuticals
Price$1.36
Change-$0.02 (-1.45%)
Volume$556.54K
Capitalization99.71M
NGNE vs ZNTL Comparison Chart in %
NGNE
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NGNE vs. ZNTL commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Buy and ZNTL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (NGNE: $20.07 vs. ZNTL: $1.38)
Brand notoriety: NGNE and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 24% vs. ZNTL: 43%
Market capitalization -- NGNE: $310.88M vs. ZNTL: $99.71M
NGNE [@Biotechnology] is valued at $310.88M. ZNTL’s [@Biotechnology] market capitalization is $99.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both NGNE and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 3 bullish TA indicator(s).

  • NGNE’s TA Score: 4 bullish, 4 bearish.
  • ZNTL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NGNE is a better buy in the short-term than ZNTL.

Price Growth

NGNE (@Biotechnology) experienced а +4.86% price change this week, while ZNTL (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.37%. For the same industry, the average monthly price growth was +0.28%, and the average quarterly price growth was +55.43%.

Reported Earning Dates

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($311M) has a higher market cap than ZNTL($99.7M). NGNE YTD gains are higher at: -12.205 vs. ZNTL (-54.455). NGNE has higher annual earnings (EBITDA): -82.02M vs. ZNTL (-152.83M). ZNTL has more cash in the bank: 281M vs. NGNE (265M). NGNE has less debt than ZNTL: NGNE (11.3M) vs ZNTL (36.7M). ZNTL has higher revenues than NGNE: ZNTL (26.9M) vs NGNE (0).
NGNEZNTLNGNE / ZNTL
Capitalization311M99.7M312%
EBITDA-82.02M-152.83M54%
Gain YTD-12.205-54.45522%
P/E RatioN/AN/A-
Revenue026.9M-
Total Cash265M281M94%
Total Debt11.3M36.7M31%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNEZNTL
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NGNE
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNMDF20.00N/A
N/A
Banca Mediolanum SPA
FDCHF1.60N/A
N/A
Funding Circle Hldgs Ltd.
JTEKY33.17N/A
N/A
JTEKT Corp.
OILCF1.70N/A
N/A
Permex Petroleum Corporation
PEBC63.30-0.10
-0.16%
Peoples Bancorp Inc.

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
-0.05%
BRNS - NGNE
51%
Loosely correlated
-1.07%
TSHA - NGNE
50%
Loosely correlated
+3.50%
BCYC - NGNE
49%
Loosely correlated
+0.72%
ZNTL - NGNE
49%
Loosely correlated
+2.22%
RNAZ - NGNE
48%
Loosely correlated
-1.33%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with NGNE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+2.22%
NGNE - ZNTL
49%
Loosely correlated
-0.05%
SYRE - ZNTL
47%
Loosely correlated
-0.54%
MGNX - ZNTL
45%
Loosely correlated
+1.25%
BEAM - ZNTL
43%
Loosely correlated
+1.33%
ORMP - ZNTL
43%
Loosely correlated
+6.78%
More